Affinity Investment Advisors LLC reduced its position in Aetna Inc. (NYSE:AET) by 18.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 90,185 shares of the company’s stock after selling 20,369 shares during the period. Aetna accounts for about 1.6% of Affinity Investment Advisors LLC’s portfolio, making the stock its 13th largest position. Affinity Investment Advisors LLC’s holdings in Aetna were worth $13,693,000 as of its most recent filing with the SEC.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. increased its position in Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares during the last quarter. Vanguard Group Inc. increased its position in Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the last quarter. AQR Capital Management LLC increased its position in Aetna by 26.0% in the first quarter. AQR Capital Management LLC now owns 3,639,077 shares of the company’s stock worth $464,165,000 after buying an additional 751,166 shares during the last quarter. UBS Asset Management Americas Inc. increased its position in Aetna by 29.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,376,132 shares of the company’s stock worth $303,076,000 after buying an additional 537,604 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. increased its position in Aetna by 251.2% in the first quarter. NN Investment Partners Holdings N.V. now owns 687,675 shares of the company’s stock worth $87,713,000 after buying an additional 491,855 shares during the last quarter. Institutional investors and hedge funds own 91.73% of the company’s stock.
Aetna Inc. (AET) traded down 0.18% during midday trading on Friday, reaching $152.15. The company’s stock had a trading volume of 1,791,311 shares. The stock’s 50-day moving average price is $154.26 and its 200 day moving average price is $139.02. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The firm has a market capitalization of $50.53 billion, a PE ratio of 33.77 and a beta of 0.54.
Aetna (NYSE:AET) last announced its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business’s revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 EPS. Equities analysts anticipate that Aetna Inc. will post $9.52 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were given a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.31%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.
TRADEMARK VIOLATION WARNING: “Affinity Investment Advisors LLC Cuts Stake in Aetna Inc. (NYSE:AET)” was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://stocknewstimes.com/2017/08/12/aetna-inc-nyseaet-stake-decreased-by-affinity-investment-advisors-llc-updated.html.
A number of research firms have recently issued reports on AET. Cantor Fitzgerald reissued an “overweight” rating and set a $175.00 price target (up previously from $150.00) on shares of Aetna in a research report on Wednesday. Deutsche Bank AG increased their price target on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Jefferies Group LLC reissued a “hold” rating and set a $163.00 price target (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Royal Bank Of Canada increased their price target on Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Finally, BidaskClub downgraded Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Eight research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $157.09.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.